Merrimack Pharmaceuticals, Inc. Operating Margin 2010-2024 | MACK

Current and historical operating margin for Merrimack Pharmaceuticals, Inc. (MACK) over the last 10 years. The current operating profit margin for Merrimack Pharmaceuticals, Inc. as of March 31, 2024 is %.
Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2015-09-30 $0.10B $-0.09B -90.20%
2015-06-30 $0.11B $-0.08B -68.42%
2015-03-31 $0.11B $-0.07B -69.52%
2014-12-31 $0.10B $-0.07B -65.05%
2014-09-30 $0.08B $-0.09B -116.88%
2014-06-30 $0.06B $-0.10B -182.14%
2014-03-31 $0.05B $-0.12B -254.35%
2013-12-31 $0.05B $-0.12B -250.00%
2013-09-30 $0.05B $-0.12B -216.67%
2013-06-30 $0.06B $-0.11B -181.03%
2013-03-31 $0.05B $-0.10B -184.62%
2012-12-31 $0.05B $-0.09B -193.75%
2012-09-30 $0.05B $-0.09B -182.98%
2012-06-30 $0.05B $-0.08B -180.00%
2012-03-31 $0.04B $-0.09B -225.00%
2011-12-31 $0.04B $-0.08B -231.43%
2011-09-30 $0.03B $-0.06B -203.57%
2011-06-30 $0.03B $-0.03B -128.00%
2011-03-31 $0.02B $0.00B 4.55%
2010-12-31 $0.02B $0.02B 100.00%